Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver Disease.

Hangkai HuangZhening LiuYanjun GuoYan ZengShuxia ShenCheng-Fu Xu

Published in: Journal of clinical gastroenterology (2024)

This study indicated that taking PPIs was associated with increased risks of NAFLD, especially severe hepatic steatosis. Awareness should be raised regarding the potential risks of NAFLD when prescribing PPIs.

Keyphrases

human health
primary care
risk assessment
climate change
drug induced